Details of the Metabolic Reaction (MR)

General Information of This Metabolic Reaction (MR) (ID: MR002338)
Formula Reactant Tasimelteon metabolite M13 Product Tasimelteon metabolite M9
Reactant Info Product Info
Metabolic Enzyme Cytochrome P450 1A2 (CYP1A2) DME Info
Cytochrome P450 2C9 (CYP2C9) DME Info
Mephenytoin 4-hydroxylase (CYP2C19) DME Info
Cytochrome P450 2D6 (CYP2D6) DME Info
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Produce The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR002340 Tasimelteon Tasimelteon metabolite M13 Oxidation - Hydroxylation Tasimelteon [1]
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR002339 Tasimelteon metabolite M13 Tasimelteon metabolite M11 Unclear Tasimelteon [1]
References
1 Clinical assessment of drug-drug interactions of tasimelteon, a novel dual melatonin receptor agonist. J Clin Pharmacol. 2015 Sep;55(9):1004-11.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.